GOSSVSRENX• 12 Months (Normalized)
GOSS vs RENX (Gossamer Bio Inc. vs RenX Enterprises Corp.)
Showing Closing Date Range from Sep, 15, 2025 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GOSS Performance $10.38
+226.42%
Gossamer Bio Inc.
Normalized Baseline0.00%
RENX Performance $1.73
-93.4%
RenX Enterprises Corp.
Normalized Baseline0.00%
Alpha Spread Margin GOSS LEADS
+319.82%
GOSS outperforming by 319.82%
GOSSRENX
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GOSS RENX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | GOSS Price | GOSS Gain (%) | RENX Price | RENX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 15, 2026 | $10.38 | +226.42% | $1.73 | -93.40% | +319.82% |
| Sep 14, 2026 | $10.70 | +236.48% | $1.69 | -93.55% | +330.03% |
| Sep 11, 2026 | $10.73 | +237.42% | $1.78 | -93.21% | +330.63% |
| Sep 10, 2026 | $11.36 | +257.23% | $1.81 | -93.09% | +350.32% |
| Sep 09, 2026 | $12.80 | +302.52% | $1.79 | -93.17% | +395.69% |
| Sep 08, 2026 | $14.40 | +352.83% | $1.79 | -93.17% | +446.00% |
| Sep 04, 2026 | $14.00 | +340.25% | $1.96 | -92.52% | +432.77% |
| Sep 03, 2026 | $14.05 | +341.76% | $2.15 | -91.79% | +433.55% |
| Sep 02, 2026 | $0.17 | -94.56% | $2.14 | -91.83% | -2.73% |
| Sep 01, 2026 | $0.17 | -94.75% | $2.06 | -92.14% | -2.61% |
| Aug 31, 2026 | $0.17 | -94.65% | $1.98 | -92.44% | -2.21% |
| Aug 28, 2026 | $0.17 | -94.65% | $2.01 | -92.35% | -2.30% |
| Aug 27, 2026 | $0.17 | -94.65% | $2.05 | -92.18% | -2.47% |
| Aug 26, 2026 | $0.17 | -94.53% | $2.02 | -92.29% | -2.24% |
| Aug 25, 2026 | $0.21 | -93.55% | $1.98 | -92.44% | -1.11% |
Page 1 of 17